Stockreport

J&J Tops Quarterly Profit Estimates on Cancer Drug Sales [BNN Bloomberg (Canada)]

Intra-Cellular Therapies Inc.  (ITCI) 
Last intra-cellular therapies inc. earnings: 3/2 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.intracellulartherapies.com/investor-relations
PDF J&J is grappling with a multibillion-dollar patent cliff as its second-biggest drug, Stelara, faces off-brand competition in the US and Europe. The company is counting [Read more]